有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (2R)-2-(3,4-dihydro-2H-1,5-benzodioxepin-7-ylsulfanyl)-N-[(2R)-2-phenylpropyl]propanamide | —— | C21H25NO3S |
|
—— | 3-[[2-(1-methylpyrazol-4-yl)-1,3-thiazol-4-yl]methylsulfanyl]-4-(2-phenylethyl)-1H-1,2,4-triazol-5-one | —— | C18H18N6OS2 |
|
—— | N-[[6-[(2S,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]methyl]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamide | —— | C20H27N5O2S |
|
—— | 2-(2,4-dimethylphenyl)sulfanyl-N-[(2R)-1-morpholin-4-ylpropan-2-yl]pyridine-3-carboxamide | —— | C21H27N3O2S |
|
—— | (2S)-4-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-3-oxo-2-phenylbutanenitrile | —— | C13H12N4OS |
|
—— | (2R)-4-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-3-oxo-2-phenylbutanenitrile | —— | C13H12N4OS |
|
—— | 2-(2,5-dimethylphenyl)sulfanyl-N-[[2-(2-methylimidazol-1-yl)pyridin-4-yl]methyl]acetamide | —— | C20H22N4OS |
|
—— | 3-(3,4-dimethylphenyl)sulfanyl-N-[[2-(2-methylimidazol-1-yl)pyridin-4-yl]methyl]propanamide | —— | C21H24N4OS |
|
—— | 3-(4-chlorophenyl)sulfanyl-N-[[2-(2-methylimidazol-1-yl)pyridin-4-yl]methyl]propanamide | —— | C19H19ClN4OS |
|
—— | (2R)-N-[4-(4-methylpiperidin-1-yl)butyl]-2-phenylsulfanylpropanamide | —— | C19H30N2OS |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[4-(4-methylpiperidin-1-yl)butyl]acetamide | —— | C18H26F2N2OS |
|
—— | 2-(2-chlorophenyl)sulfanyl-N-[4-[(2S)-2-methylpiperidin-1-yl]butyl]acetamide | —— | C18H27ClN2OS |
|
—— | N-cyclopropyl-2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[[(3S)-oxolan-3-yl]methyl]acetamide | —— | C18H24N4O3S |
|
—— | 3-(2-bromophenyl)sulfanyl-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]propanamide | —— | C15H20BrNO2S |
|
—— | 3-(2-bromophenyl)sulfanyl-N-(6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-3-ylmethyl)propanamide | —— | C15H17BrN4OS |
|
—— | 3-(2-bromophenyl)sulfanyl-N-[(2S)-2-morpholin-4-ylpropyl]propanamide | —— | C16H23BrN2O2S |
|
—— | 2-(4-fluorophenyl)sulfanyl-N-[[6-[(2S)-2-methylmorpholin-4-yl]pyridin-3-yl]methyl]acetamide | —— | C19H22FN3O2S |
|
—— | N-[[6-[(2R,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]methyl]-2-(2,5-dimethylphenyl)sulfanylacetamide | —— | C22H29N3O2S |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[[6-[(2R,6S)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]methyl]acetamide | —— | C20H23F2N3O2S |
|
—— | 2-[[4-ethyl-5-(furan-2-yl)-1,2,4-triazol-3-yl]sulfanyl]-N-[(5-ethylthiophen-2-yl)methyl]acetamide | —— | C17H20N4O2S2 |
|
—— | 4-(4-chlorophenyl)sulfanyl-N-(1-pyrimidin-2-ylpiperidin-4-yl)butanamide | —— | C19H23ClN4OS |
|
—— | 5-[[5-[(3R,5R)-3,5-dimethylpiperidin-1-yl]-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanylmethyl]-3-(2-methylpropyl)-1,2,4-oxadiazole | —— | C21H30N6O2S |
|
—— | 3-tert-butyl-5-[[4-[[(2S)-oxolan-2-yl]methyl]-5-thiophen-2-yl-1,2,4-triazol-3-yl]sulfanylmethyl]-1,2,4-oxadiazole | —— | C18H23N5O2S2 |
|
—— | 3-(2-bromophenyl)sulfanyl-N-methyl-N-(1-propan-2-ylpiperidin-4-yl)propanamide | —— | C18H27BrN2OS |
|
—— | N-[(2R)-butan-2-yl]-2-pyridin-4-ylsulfanylacetamide | —— | C11H16N2OS |
|
—— | N-[(2S)-butan-2-yl]-3-(4-fluorophenyl)sulfanylpropanamide | —— | C13H18FNOS |
|
—— | 1-[(2S,6S)-2,6-dimethylmorpholin-4-yl]-4-phenylsulfanylbutan-1-one | —— | C16H23NO2S |
|
—— | N-[2-(diethylamino)ethyl]-4-phenylsulfanylbutanamide | —— | C16H26N2OS |
|
—— | N-(2-cyclopentylsulfanylethyl)-3-phenylsulfanylpropanamide | —— | C16H23NOS2 |
|
—— | N-(2-phenylsulfanylphenyl)-3-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)propanamide | —— | C22H18N4O2S |
|
—— | 2-(2,4-difluorophenyl)sulfanyl-N-[(3S)-1-pyrimidin-2-ylpiperidin-3-yl]acetamide | —— | C17H18F2N4OS |
|
—— | 4-(4-chlorophenyl)sulfanyl-N-[(3R)-1-pyrimidin-2-ylpiperidin-3-yl]butanamide | —— | C19H23ClN4OS |
|
—— | N-[(3,5-dimethyl-1,2-oxazol-4-yl)methyl]-N-methyl-4-phenylsulfanylbutanamide | —— | C17H22N2O2S |
|
—— | 4-(4-chlorophenyl)sulfanyl-N-[[6-(dimethylamino)pyridin-3-yl]methyl]butanamide | —— | C18H22ClN3OS |
|
—— | (2R)-2-(4-chlorophenyl)sulfanyl-N'-(4-methoxypyrimidin-2-yl)propanehydrazide | —— | C14H15ClN4O2S |
|
—— | 3-(4,6-dimethyl-2-methylsulfanylpyrimidin-5-yl)-1-[(2R)-2-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-yl)pyrrolidin-1-yl]propan-1-one | —— | C21H30N6OS |
|
—— | 3-(2-benzylsulfanyl-6-methyl-4-oxo-1H-pyrimidin-5-yl)-N-pentyl-N-propan-2-ylpropanamide | —— | C23H33N3O2S |
|
—— | (2R)-2-(4-chlorophenyl)sulfanyl-N-methyl-N-[(5-methyl-1,2-oxazol-3-yl)methyl]propanamide | —— | C15H17ClN2O2S |
|
—— | 2-(4-chlorophenyl)sulfanyl-N-[(2S)-2-morpholin-4-yl-2-[(3R)-oxolan-3-yl]ethyl]acetamide | —— | C18H25ClN2O3S |
|
—— | 2-(2,5-dimethylphenyl)sulfanyl-N-[(2R)-2-morpholin-4-yl-2-[(3R)-oxolan-3-yl]ethyl]acetamide | —— | C20H30N2O3S |
|
—— | (2R)-2-(4-chlorophenyl)sulfanyl-N-cyclopropyl-N-(pyridin-4-ylmethyl)propanamide | —— | C18H19ClN2OS |
|
—— | 2-[2-Ethyl-6-(methoxymethyl)pyrimidin-4-yl]sulfanylacetic acid | —— | C10H14N2O3S |
|
—— | 2-(6-Ethyl-5-methyl-2-propan-2-ylpyrimidin-4-yl)sulfanylacetic acid | —— | C12H18N2O2S |
|
—— | (2,6-Diethyl-pyrimidin-4-ylsulfanyl)-acetic acid | —— | C10H14N2O2S |
|
—— | 2-(2-Ethyl-6-propylpyrimidin-4-yl)sulfanylacetic acid | —— | C11H16N2O2S |
|
—— | 2-(5-Ethyl-2,6-dimethylpyrimidin-4-yl)sulfanylacetic acid | —— | C10H14N2O2S |
|
—— | (6R)-6-(bromomethyl)-N-prop-2-enyl-5,6-dihydro-[1,3]thiazolo[2,3-c][1,2,4]triazol-3-amine | —— | C8H11BrN4S |
|
—— | 2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)sulfanyl]-N-[(1S,3S)-3-methylcyclohexyl]acetamide | —— | C17H24N4OS2 |
|
—— | 2-[(4-benzyl-5-methyl-1,2,4-triazol-3-yl)sulfanyl]-N-[(1S)-1-(2-fluorophenyl)ethyl]-N-methylacetamide | —— | C21H23FN4OS |
|
—— | (2R)-2-amino-3-(3-methylphenyl)sulfanylpropanenitrile | —— | C10H12N2S |
|